{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T04:22:18Z","timestamp":1787458938083,"version":"build-2736575974"},"reference-count":79,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Topical diclofenac is recommended over oral non-steroidal anti-inflammatory drugs (NSAIDs) for osteoarthritis, particularly in older adults and those with comorbidities, on the assumption that low systemic absorption limits renal effects. Whether this presumed safety extends to patients already at increased risk of kidney injury has not been systematically evaluated. This review assessed the evidence on renal outcomes of topical diclofenac in adults. Materials and Methods: We conducted a systematic review (PROSPERO CRD420261393454) of studies reporting renal outcomes after topical diclofenac exposure. PubMed, Embase, Web of Science, and Scopus were searched from inception to 19 April 2026. Studies were stratified a priori into increased-renal-risk and general populations and synthesised separately, without pooling. Risk of bias was assessed with RoB 2, ROBINS-I, and JBI tools, certainty with GRADE, and synthesis followed the SWiM framework. Results: Eighteen studies, contributing data from more than 500,000 participants, were included; 14 underwent primary risk-of-bias appraisal (three at low, three at serious or high risk). In general populations, topical diclofenac produced little to no change in serum creatinine or creatinine clearance and smaller renal effects than oral diclofenac, providing high-certainty evidence of a favourable profile. In increased-renal-risk populations, one adjusted cohort reported higher acute kidney injury (AKI) risk among topical NSAID users, although exposure was predominantly to non-diclofenac agents; within the same cohort, topical NSAIDs carried lower risk than systemic NSAIDs. No study evaluated early renal injury biomarkers; certainty was moderate owing to indirectness. Conclusions: Relative to oral diclofenac, topical diclofenac shows a favourable renal safety profile, with high-certainty evidence in general populations. In adults at increased renal risk, moderate-certainty evidence derived from predominantly non-diclofenac exposure over short observation windows cannot exclude a modest excess of any-stage AKI; renal risk therefore appears reduced rather than absent. Diclofenac-specific studies in chronic kidney disease using sensitive biomarkers and longer follow-up are needed.<\/jats:p>","DOI":"10.3390\/medicina62081606","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T08:14:01Z","timestamp":1787300041000},"page":"1606","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal Safety of Topical Diclofenac in Adults with Increased Renal Risk: A Systematic Review"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1766-8060","authenticated-orcid":false,"given":"Eric-Oliviu","family":"Co\u0219ovanu","sequence":"first","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5166-1970","authenticated-orcid":false,"given":"Elena-Teona","family":"Co\u0219ovanu","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9036-1534","authenticated-orcid":false,"given":"Teodora Ana","family":"Balan","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9989-1653","authenticated-orcid":false,"given":"Cezar Ilie","family":"Foia","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2343-5782","authenticated-orcid":false,"given":"Cosmin Gabriel","family":"Tar\u021b\u0103u","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2268-0000","authenticated-orcid":false,"given":"Tiberiu","family":"Lunguleac","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelian-Bogdan","family":"Stana","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1239-8058","authenticated-orcid":false,"given":"Antoneta Dacia","family":"Petroaie","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6321-7253","authenticated-orcid":false,"given":"Simona Eliza","family":"Giu\u0219c\u0103","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6348-2954","authenticated-orcid":false,"given":"Elena Adorata","family":"Coman","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0979-0200","authenticated-orcid":false,"given":"Demetra","family":"Socolov","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-8991","authenticated-orcid":false,"given":"Raluca Anca","family":"Balan","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1811-7923","authenticated-orcid":false,"given":"Ramona Gabriela","family":"Ursu","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0104-8503","authenticated-orcid":false,"given":"Irina-Draga","family":"C\u0103runtu","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7983-3811","authenticated-orcid":false,"given":"Liliana","family":"Mititelu-Tar\u021b\u0103u","sequence":"additional","affiliation":[{"name":"\u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar4174","article-title":"Use of NSAIDs in Treating Patients with Arthritis","volume":"15","author":"Crofford","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI Recommendations for the Management of Hip and Knee Osteoarthritis, Part II: OARSI Evidence-Based, Expert Consensus Guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthr. Cartil."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5114\/reum.2018.76816","article-title":"Diclofenac in the treatment of pain in patients with rheumatic diseases","volume":"56","year":"2018","journal-title":"Reumatologia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/S0002-9343(99)00113-8","article-title":"Nephrotoxicity of Nonsteroidal Anti-Inflammatory Drugs: Physiologic Foundations and Clinical Implications","volume":"106","author":"Whelton","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/oxfordjournals.qjmed.a069100","article-title":"Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure","volume":"88","author":"Evans","year":"1995","journal-title":"QJM"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/aje\/kwj331","article-title":"Association of Selective and Conventional Nonsteroidal Antiinflammatory Drugs with Acute Renal Failure: A Population-Based, Nested Case-Control Analysis","volume":"164","author":"Schneider","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejim.2015.03.008","article-title":"Individual Non-Steroidal Anti-Inflammatory Drugs and Risk of Acute Kidney Injury: A Systematic Review and Meta-Analysis of Observational Studies","volume":"26","author":"Ungprasert","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhang, X., Donnan, P.T., Bell, S., and Guthrie, B. (2017). Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: Systematic review and meta-analysis. BMC Nephrol., 18.","DOI":"10.1186\/s12882-017-0673-8"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2165\/00003088-199733030-00003","article-title":"Clinical pharmacokinetics of diclofenac: Therapeutic insights and pitfalls","volume":"33","author":"Davies","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.21540","article-title":"More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib","volume":"54","author":"Hinz","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00003088-199936030-00002","article-title":"Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid","volume":"36","author":"Day","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00167-013-2408-0","article-title":"Penetration of topical diclofenac sodium 4% spray gel into the synovial tissue and synovial fluid of the knee: A randomized clinical trial","volume":"22","author":"Efe","year":"2014","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1080\/03007995.2017.1352497","article-title":"Skin penetration and tissue permeation after topical administration of diclofenac","volume":"33","author":"Hagen","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3565(25)38459-4","article-title":"Skin permeability and local tissue concentrations of non-steroidal anti-inflammatory drugs after topical application","volume":"268","author":"Singh","year":"1994","journal-title":"J. Pharm. Exp. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2125.1991.tb05576.x","article-title":"Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease","volume":"31","author":"Radermacher","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1023\/A:1011911302005","article-title":"In Vivo Bioavailability and Metabolism of Topical Diclofenac Lotion in Human Volunteers","volume":"15","author":"Hui","year":"1998","journal-title":"Pharm. Res."},{"key":"ref_17","first-page":"1092","article-title":"The Percutaneous Absorption of Diclofenac","volume":"36","author":"Riess","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/bdd.2510150602","article-title":"Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel","volume":"15","author":"Sioufi","year":"1994","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1185\/030079907X242584","article-title":"Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability","volume":"23","author":"Brune","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI Guidelines for the Non-Surgical Management of Knee, Hip, and Polyarticular Osteoarthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_22","unstructured":"National Institute for Health and Care Excellence (NICE) (2022). Osteoarthritis in over 16s: Diagnosis and Management, NICE. NICE Guideline NG226."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"(2009). American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological Management of Persistent Pain in Older Persons. J. Am. Geriatr. Soc., 57, 1331\u20131346.","DOI":"10.1111\/j.1532-5415.2009.02376.x"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/11584880-000000000-00000","article-title":"Safety and Efficacy of Topical Diclofenac Sodium Gel for Knee Osteoarthritis in Elderly and Younger Patients: Pooled Data from Three Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicentre Trials","volume":"28","author":"Baraf","year":"2011","journal-title":"Drugs Aging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2009.09.002","article-title":"Randomized Controlled Trial of Diclofenac Sodium Gel in Knee Osteoarthritis","volume":"39","author":"Barthel","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3810\/psm.2010.06.1779","article-title":"Safety and Efficacy of Topical Diclofenac Sodium 1% Gel in Knee Osteoarthritis: A Randomized Controlled Trial","volume":"38","author":"Baraf","year":"2010","journal-title":"Phys. Sportsmed."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1185\/030079908X273066","article-title":"Topical diclofenac and its role in pain and inflammation: An evidence-based review","volume":"24","author":"Zacher","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_28","first-page":"CD007400","article-title":"Topical NSAIDs for Chronic Musculoskeletal Pain in Adults","volume":"9","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_29","first-page":"CD007402","article-title":"Topical NSAIDs for acute musculoskeletal pain in adults","volume":"6","author":"Derry","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_30","first-page":"CD007400","article-title":"Topical NSAIDs for chronic musculoskeletal pain in adults","volume":"4","author":"Derry","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/bmj.38159.639028.7C","article-title":"Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: Meta-analysis of randomized controlled trials","volume":"329","author":"Lin","year":"2004","journal-title":"BMJ"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.joca.2018.08.008","article-title":"The relative efficacy of topical non-steroidal anti-inflammatory drugs and capsaicin in osteoarthritis: A network meta-analysis of randomized controlled trials","volume":"26","author":"Persson","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Chen, Z.R., Chen, B.K., Li, P., and Feng, K. (2025). Efficacy and Safety of Different Topical Diclofenac Formulations for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Short-Term and Long-Term Treatment Comparisons. BMC Musculoskelet. Disord., 26.","DOI":"10.1186\/s12891-025-08465-7"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40266-019-00661-0","article-title":"Safety of topical non-steroidal anti-inflammatory drugs in osteoarthritis: Outcomes of a systematic review and meta-analysis","volume":"36","author":"Honvo","year":"2019","journal-title":"Drugs Aging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1185\/03007995.2010.550606","article-title":"Safety profile of topical diclofenac: A meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions","volume":"27","author":"Taylor","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mason, L., Moore, R.A., Edwards, J.E., Derry, S., and McQuay, H.J. (2004). Topical NSAIDs for chronic musculoskeletal pain: Systematic review and meta-analysis. BMC Musculoskelet. Disord., 5.","DOI":"10.1186\/1471-2474-5-28"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1213\/00000539-199901000-00028","article-title":"Diclofenac Does Not Decrease Renal Blood Flow or Glomerular Filtration in Elderly Patients Undergoing Orthopedic Surgery","volume":"88","author":"Fredman","year":"1999","journal-title":"Anesth. Analg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/bja\/69.5.451","article-title":"Effect of diclofenac on renal function and prostacyclin generation after surgery","volume":"69","author":"Power","year":"1992","journal-title":"Br. J. Anaesth."},{"key":"ref_39","first-page":"CD002765","article-title":"Effects of Nonsteroidal Anti-Inflammatory Drugs on Postoperative Renal Function in Adults with Normal Renal Function","volume":"2","author":"Lee","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/09546639409084542","article-title":"Topical non-steroidal anti-inflammatory drugs: A review of their use and toxicity","volume":"5","author":"Halpern","year":"1994","journal-title":"J. Dermatol. Treat."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/bmj.320.7227.93","article-title":"Acute renal failure induced by topical ketoprofen","volume":"320","author":"Krummel","year":"2000","journal-title":"BMJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bmj.308.6921.110","article-title":"Renal disease and use of topical non-steroidal anti-inflammatory drugs","volume":"308","author":"Andrews","year":"1994","journal-title":"BMJ"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e8525","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent Use of Diuretics, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers with Non-Steroidal Anti-Inflammatory Drugs and Risk of Acute Kidney Injury: Nested Case-Control Study","volume":"346","author":"Lapi","year":"2013","journal-title":"BMJ"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/bcp.70263","article-title":"Acute Kidney Injury and Morbi-Mortality Associated with \u201cTriple Whammy\u201d Combination: Systematic Review and Meta-Analysis","volume":"91","author":"Calvo","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/ckj\/sfx080","article-title":"2017 update on pain management in patients with chronic kidney disease","volume":"10","author":"Pham","year":"2017","journal-title":"Clin. Kidney J."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"(2024). Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int., 105, S117\u2013S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"ref_47","unstructured":"(2012). Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. Suppl., 2, 1\u2013138."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A New Equation to Estimate Glomerular Filtration Rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis Without Meta-Analysis (SWiM) in Systematic Reviews: Reporting Guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"ref_51","first-page":"2002","article-title":"Equivalence Study of a Topical Diclofenac Solution (Pennsaid) Compared with Oral Diclofenac in Symptomatic Treatment of Osteoarthritis of the Knee: A Randomized Controlled Trial","volume":"31","author":"Tugwell","year":"2004","journal-title":"J. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.03.008","article-title":"Efficacy and Safety of Topical Diclofenac Containing Dimethyl Sulfoxide (DMSO) Compared with Those of Topical Placebo, DMSO Vehicle and Oral Diclofenac for Knee Osteoarthritis","volume":"143","author":"Simon","year":"2009","journal-title":"Pain"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/JPR.S20965","article-title":"Diclofenac Topical Solution Compared with Oral Diclofenac: A Pooled Safety Analysis","volume":"4","author":"Roth","year":"2011","journal-title":"J. Pain Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A Tool for Assessing Risk of Bias in Non-Randomised Studies of Interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_56","first-page":"2127","article-title":"Methodological Quality of Case Series Studies: An Introduction to the JBI Critical Appraisal Tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-Bias VISualization (robvis): An R Package and Shiny Web App for Visualizing Risk-of-Bias Assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res. Synth. Methods"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e076754","DOI":"10.1136\/bmj-2023-076754","article-title":"ROB-ME: A Tool for Assessing Risk of Bias Due to Missing Evidence in Systematic Reviews with Meta-Analysis","volume":"383","author":"Page","year":"2023","journal-title":"BMJ"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.01.012","article-title":"GRADE Guidelines: 18. How ROBINS-I and Other Tools to Assess Risk of Bias in Nonrandomized Studies Should Be Used to Rate the Certainty of a Body of Evidence","volume":"111","author":"Cuello","year":"2019","journal-title":"J. Clin. Epidemiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE Guidelines 26: Informative Statements to Communicate the Findings of Systematic Reviews of Interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3899\/jrheum.081316","article-title":"Diclofenac Sodium Gel in Patients with Primary Hand Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"36","author":"Altman","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1503\/cmaj.1031793","article-title":"Effect of a Topical Diclofenac Solution for Relieving Symptoms of Primary Osteoarthritis of the Knee: A Randomized Controlled Trial","volume":"171","author":"Bookman","year":"2004","journal-title":"CMAJ"},{"key":"ref_64","first-page":"2384","article-title":"Efficacy of Topical Diclofenac Diethylamine Gel in Osteoarthritis of the Knee","volume":"32","author":"Niethard","year":"2005","journal-title":"J. Rheumatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1001\/archinte.164.18.2017","article-title":"Efficacy and Safety of a Topical Diclofenac Solution (Pennsaid) in the Treatment of Primary Osteoarthritis of the Knee: A Randomized, Double-Blind, Vehicle-Controlled Clinical Trial","volume":"164","author":"Roth","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0091270009336234","article-title":"Systemic Bioavailability of Topical Diclofenac Sodium Gel 1% Versus Oral Diclofenac Sodium in Healthy Volunteers","volume":"50","author":"Kienzler","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"ref_67","first-page":"UC11","article-title":"Efficacy of Diclofenac and Ketoprofen Transdermal Patches for Postoperative Analgesia and Their Effect on Renal Functions in Patients Undergoing Percutaneous Nephrolithotomy: A Randomised Clinical Study","volume":"19","author":"Baheti","year":"2025","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/jphp.13105","article-title":"Single-Dose Diclofenac in Healthy Volunteers Can Cause Decrease in Renal Perfusion Measured by Functional Magnetic Resonance Imaging","volume":"71","author":"Hellms","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3810\/psm.2011.09.1918","article-title":"An Open-Label, Long-Term Safety and Tolerability Trial of Diclofenac Sodium 1% Gel in Patients with Knee Osteoarthritis","volume":"39","author":"Peniston","year":"2011","journal-title":"Phys. Sportsmed."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2147\/CIA.S35416","article-title":"Long-Term Tolerability of Topical Diclofenac Sodium 1% Gel for Osteoarthritis in Seniors and Patients with Comorbidities","volume":"7","author":"Peniston","year":"2012","journal-title":"Clin. Interv. Aging"},{"key":"ref_71","first-page":"734","article-title":"The Effectiveness of Zingiber Zerumbet Ointment Compared to Diclofenac Gel on Clinical Symptoms of Patients with Knee Osteoarthritis: A Double-Blind Randomized Controlled Trial (RCT)","volume":"24","author":"Shariatpanahi","year":"2020","journal-title":"Med. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11255-022-03344-9","article-title":"Non-Steroidal Anti-Inflammatory Drugs in Chronic Kidney Disease and Risk of Acute Adverse Kidney Events According to Route of Administration","volume":"55","author":"Teo","year":"2023","journal-title":"Int. Urol. Nephrol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s40122-025-00723-9","article-title":"Evaluating the Real-World Use of Topical Diclofenac Sodium Gel 1% Using US Longitudinal Electronic Health Records Database: A Study Supporting OTC Switch","volume":"14","author":"Sicignano","year":"2025","journal-title":"Pain Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/CIA.S30884","article-title":"Pooled Safety Analysis of Diclofenac Sodium Topical Solution 1.5% (w\/w) in the Treatment of Osteoarthritis in Patients Aged 75 Years or Older","volume":"7","author":"Roth","year":"2012","journal-title":"Clin. Interv. Aging"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3810\/pgm.2011.11.2507","article-title":"Diclofenac Sodium Topical Solution 1.5% w\/w with Dimethyl Sulfoxide Compared with Placebo for the Treatment of Osteoarthritis: Pooled Safety Results","volume":"123","author":"Roth","year":"2011","journal-title":"Postgrad. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjopharm.2011.12.002","article-title":"Tolerability of Topical Diclofenac Sodium 1% Gel for Osteoarthritis in Seniors and Patients with Comorbidities","volume":"10","author":"Baraf","year":"2012","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_77","unstructured":"GBD 2023 Chronic Kidney Disease Collaborators (2025). Global, Regional, and National Burden of Chronic Kidney Disease in Adults, 1990\u20132023, and Its Attributable Risk Factors: A Systematic Analysis for the Global Burden of Disease Study 2023. Lancet, 406, 2461\u20132482."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s42506-018-0005-2","article-title":"Non-Steroidal Anti-Inflammatory Drugs among Chronic Kidney Disease Patients: An Epidemiological Study","volume":"94","author":"Hegazy","year":"2019","journal-title":"J. Egypt. Public Health Assoc."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"100438","DOI":"10.1016\/j.lanepe.2022.100438","article-title":"Prevalence, Outcomes, and Cost of Chronic Kidney Disease in a Contemporary Population of 2.4 Million Patients from 11 Countries: The CaReMe CKD Study","volume":"20","author":"Bodegard","year":"2022","journal-title":"Lancet Reg. Health Eur."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1606\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T04:15:02Z","timestamp":1787458502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":79,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["medicina62081606"],"URL":"https:\/\/doi.org\/10.3390\/medicina62081606","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}